Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...

RBC Capital analyst Daniel Perlin maintained a Buy rating on Global Payments (GPN – Research Report) yesterday and set a price target of ...

Received overwhelming shareholder support in favour of take-private transaction with AditxtAdvanced key pipeline programs, engaged regulatory ...

Aston Martin Aramco Formula One Team inked a multi-year deal with Coinbase today, and every single dollar of it was paid in ...

Peter Mandelson, the new British ambassador to Washington, has always been keen to suck up to the wealthy. He should have no ...